UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

for the quarterly period ended April 2, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

for the transition period from ________________ to _______________

 

Commission File Number 001-35383

 

THE EASTERN COMPANY

(Exact name of registrant as specified in its charter)

 

 

Connecticut

 

06-0330020

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

112 Bridge Street, Naugatuck, Connecticut

 

06770

(Address of principal executive offices)

 

(Zip Code)

 

(203)-729-2255

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, No Par Value

EML

NASDAQ Global Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated Filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of April 2, 2022, 6,239,824 shares of the registrant’s common stock, no par value per share, were issued and outstanding.

 

 

 

 

The Eastern Company

Form 10-Q

 

FOR THE QUARTERLY PERIOD ENDED APRIL 2, 2022

 

TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PART I

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements

 

 

3

 

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

16

 

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

24

 

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

 

24

 

 

 

 

 

 

 

PART II

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

 

 

25

 

 

 

 

 

 

 

Item 1A.

Risk Factors

 

 

25

 

 

 

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

25

 

 

 

 

 

 

 

Item 3.

Defaults Upon Senior Securities

 

 

25

 

 

 

 

 

 

 

Item 4.

Mine Safety Disclosures

 

 

25

 

 

 

 

 

 

 

Item 5.

Other Information

 

 

25

 

 

 

 

 

 

 

Item 6

Exhibits

 

 

26

 

 

 

 

 

 

 

 

Signatures

 

 

27

 

 

 
2

Table of Contents

 

PART 1 – FINANCIAL INFORMATION

 

ITEM 1 – FINANCIAL STATEMENTS                                                          

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Net sales

 

$69,014,648

 

 

$61,773,433

 

Cost of products sold

 

 

(54,438,968)

 

 

(46,264,163)

Gross margin

 

 

14,575,680

 

 

 

15,509,270

 

 

 

 

 

 

 

 

 

 

Product development expense

 

 

(1,197,008)

 

 

(1,017,563)

Selling and administrative expenses

 

 

(9,865,614)

 

 

(8,944,393)

Operating profit

 

 

3,513,058

 

 

 

5,547,314

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(434,335)

 

 

(527,144)

Other income

 

 

488,520

 

 

 

2,426,740

 

Income from continuing operations before income taxes

 

 

3,567,243

 

 

 

7,446,910

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(881,125)

 

 

(1,767,552)

Net income from continuing operations

 

 

2,686,118

 

 

 

5,679,358

 

 

 

 

 

 

 

 

 

 

Discontinued Operations (see note B )

 

 

 

 

 

 

 

 

Income from operations of discontinued operations

 

 

471,187

 

 

 

211,181

 

Income tax expense

 

 

(126,867)

 

 

(49,712)

Income from discontinued operations

 

 

344,320

 

 

 

161,469

 

 

 

 

 

 

 

 

 

 

Net income

 

$3,030,438

 

 

$5,840,827

 

 

 

 

 

 

 

 

 

 

Earnings per share from continuing operations:

 

 

 

 

 

 

 

 

Basic

 

$0.43

 

 

$0.90

 

 

 

 

 

 

 

 

 

 

Diluted

 

$0.43

 

 

$0.90

 

 

 

 

 

 

 

 

 

 

Earnings per share from discontinued operations:

 

 

 

 

 

 

 

 

Basic

 

$0.06

 

 

$0.03

 

 

 

 

 

 

 

 

 

 

Diluted

 

$0.05

 

 

$0.03

 

 

 

 

 

 

 

 

 

 

Total earnings per share:

 

 

 

 

 

 

 

 

Basic

 

$0.49

 

 

$0.93

 

 

 

 

 

 

 

 

 

 

Diluted

 

$0.48

 

 

$0.93

 

 

 

 

 

 

 

 

 

 

Cash dividends per share:

 

$0.11

 

 

$0.11

 

             

See accompanying notes.                 

 

 
3

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Net income

 

$3,030,438

 

 

$5,840,827

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in foreign currency translation

 

 

202,281

 

 

 

(79,054)

 

 

 

 

 

 

 

 

 

Change in fair value of interest rate swap, net of tax cost of:

 

 

 

 

 

 

 

 

2022 - $333,635; 2021 - $130,501

 

 

1,056,511

 

 

 

413,245

 

 

 

 

 

 

 

 

 

 

Change in pension and postretirement benefit costs, net of taxes of:

 

 

 

 

 

 

 

 

2022 - $92,235; 2021 - $92,194

 

 

313,408

 

 

 

295,744

 

Total other comprehensive income

 

 

1,572,200

 

 

 

629,935

 

Comprehensive income

 

$4,602,638

 

 

$6,470,762

 

 

See accompanying notes.                 

 

 
4

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

April 2, 2022

 

 

January 1, 2022

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$5,073,524

 

 

$6,168,304

 

Accounts receivable, less allowances: 2022 - $532,000; 2021 - $515,000

 

 

46,965,504

 

 

 

43,151,500

 

Inventories

 

 

67,777,718

 

 

 

62,862,342

 

Current portion of notes receivable

 

 

1,027,125

 

 

 

1,027,125

 

Prepaid expenses and other assets

 

 

7,831,437

 

 

 

6,943,691

 

Current assets held for sale

 

 

4,671,915

 

 

 

3,521,899

 

Total Current Assets

 

 

133,347,223

 

 

 

123,674,861

 

 

 

 

 

 

 

 

 

 

Property, Plant and Equipment

 

 

55,234,222

 

 

 

56,935,080

 

Accumulated depreciation

 

 

(28,641,459)

 

 

(28,631,329)

Property, Plant and Equipment, Net

 

 

26,592,763

 

 

 

28,303,751

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

72,225,885

 

 

 

72,211,873

 

Trademarks

 

 

5,484,923

 

 

 

5,409,720

 

Patents and other intangibles net of accumulated amortization

 

 

21,865,328

 

 

 

22,863,497

 

Long term notes receivable, less current portion

 

 

2,551,478

 

 

 

2,726,698

 

Right of Use Assets

 

 

11,430,632

 

 

 

11,138,535

 

Total Other Assets

 

 

113,558,246

 

 

 

114,350,323

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$273,498,232

 

 

$266,328,935

 

            

See accompanying notes.                 

 

 
5

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

April 2, 2022

 

 

January 1, 2022

 

 

 

(unaudited)

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

Accounts payable

 

$33,654,638

 

 

$29,633,974

 

Accrued compensation

 

 

2,584,565

 

 

 

4,375,867

 

Other accrued expenses

 

 

2,481,396

 

 

 

4,808,000

 

Current portion of lease liability

 

 

2,715,550

 

 

 

2,664,895

 

Current portion of long-term debt

 

 

7,500,000

 

 

 

7,500,000

 

Current liabilities held for sale

 

 

1,226,417

 

 

 

580,990

 

Total Current Liabilities

 

 

50,162,566

 

 

 

49,563,726

 

 

 

 

 

 

 

 

 

 

Deferred income taxes

 

 

1,151,759

 

 

 

1,151,759

 

Other long-term liabilities

 

 

668,354

 

 

 

668,354

 

Lease liability

 

 

8,815,587

 

 

 

8,639,339

 

Long-term debt, less current portion

 

 

66,960,231

 

 

 

63,813,522

 

Accrued other postretirement benefits

 

 

1,299,767

 

 

 

1,284,589

 

Accrued pension cost

 

 

26,580,732

 

 

 

26,605,382

 

Total Liabilities

 

 

155,638,996

 

 

 

151,726,671

 

 

 

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

 

 

 

Voting Preferred Stock, no par value:

 

 

 

 

 

 

 

 

Authorized and unissued: 1,000,000 shares

 

 

 

 

 

 

 

 

Nonvoting Preferred Stock, no par value:

 

 

 

 

 

 

 

 

Authorized and unissued: 1,000,000 shares

 

 

 

 

 

 

 

 

Common Stock, no par value, Authorized: 50,000,000 shares

 

 

32,841,476

 

 

 

32,620,008

 

Issued: 9,034,387 shares in 2022 and 9,029,852 shares in 2021

 

 

 

 

 

 

 

 

Outstanding: 6,239,824 shares in 2022 and 6,265,527 shares in 2021

 

 

 

 

 

 

 

 

Treasury Stock: 2,794,563 shares in 2022 and 2,764,325 shares in 2021

 

 

(21,674,502)

 

 

(20,907,613)

Retained earnings

 

 

131,652,818

 

 

 

129,422,625

 

Accumulated other comprehensive income (loss):

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

1,020,727

 

 

 

818,446

 

Unrealized gain (loss) on interest rate swap, net of tax

 

 

700,523

 

 

 

(355,988)

Unrecognized net pension and postretirement benefit costs, net of tax

 

 

(26,681,806)

 

 

(26,995,214)

Accumulated other comprehensive loss

 

 

(24,960,556)

 

 

(26,532,756)

Total Shareholders’ Equity

 

 

117,859,236

 

 

 

114,602,264

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$273,498,232

 

 

$266,328,935

 

        

See accompanying notes.                 

 

 
6

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Operating Activities

 

 

 

 

 

 

Net income

 

$3,030,438

 

 

$5,840,827

 

Less: income from discontinued operations

 

 

344,320

 

 

 

161,469

 

Income from continuing operations

 

$2,686,118

 

 

$5,679,358

 

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,830,427

 

 

 

1,809,609

 

Unrecognized pension and postretirement benefits

 

 

247,133

 

 

 

(674,262)

Loss (gain) on sale of equipment and other assets

 

 

268,770

 

 

 

(1,601,812)

Provision for doubtful accounts

 

 

19,740

 

 

 

73,097

 

Stock compensation expense

 

 

221,468

 

 

 

278,258

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(3,951,314)

 

 

(3,942,502)

Inventories

 

 

(4,902,631)

 

 

(513,863)

Prepaid expenses and other

 

 

(1,075,545)

 

 

(798,273)

Other assets

 

 

(89,366)

 

 

(156,726)

Accounts payable

 

 

3,526,499

 

 

 

1,075,130

 

Accrued compensation

 

 

(1,858,898)

 

 

(1,116,703)

Other accrued expenses

 

 

(478,878)

 

 

1,140,223

 

Net cash (used in) provided by operating activities

 

 

(3,556,477)

 

 

1,251,534

 

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

Payments received from notes receivable

 

 

175,220

 

 

 

68,325

 

Proceeds from sale of equipment

 

 

1,371,073

 

 

 

1,993,744

 

Purchases of property, plant and equipment

 

 

(572,047)

 

 

(671,964)

Net cash provided by investing activities

 

 

974,246

 

 

 

1,390,105

 

 

 

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

Proceeds from short term borrowings (revolver)

 

 

5,000,000

 

 

 

 

Principal payments on long-term debt

 

 

(1,852,107)

 

 

(1,162,045)

Financing leases, net

 

 

(92,111)

 

 

(9,875)

Purchase common stock for treasury

 

 

(766,889)

 

 

 

Dividends paid

 

 

(687,180)

 

 

(684,702)

Net cash provided by (used in) financing activities

 

 

1,601,713

 

 

 

(1,856,622)

 

 

 

 

 

 

 

 

 

Discontinued Operations

 

 

 

 

 

 

 

 

Cash (used in) provided by operating activities

 

 

(396,936)

 

 

848,523

 

Cash used in investing activities

 

 

-

 

 

 

(247,625)

Cash (used in) provided by discontinued operations

 

 

(396,936)

 

 

600,898

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

(22,903)

 

 

(22,881)

Net change in cash and cash equivalents

 

 

(1,400,357)

 

 

1,363,034

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

 

6,602,429

 

 

 

16,101,635

 

Cash and cash equivalents at end of period ¹

 

$5,202,072

 

 

$17,464,669

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Interest

 

$463,080

 

 

$685,520

 

Income taxes

 

 

110,917

 

 

 

21,100

 

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities

 

 

 

 

 

 

 

 

Right of use asset

 

 

292,097

 

 

 

114,471

 

Lease liability

 

 

(226,903)

 

 

(104,595)

      

¹ includes cash from assets held for sale of $0.1 million as of April 2, 2022 and $1.5 million as of April 3, 2021                 

 

 
7

Table of Contents

 

THE EASTERN COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

April 2, 2022

 

Note A – Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X and do not include all the information and footnotes required by generally accepted accounting principles in the United States (“GAAP”) for complete financial statements. Refer to the consolidated financial statements of The Eastern Company (together with its consolidated subsidiaries, the “Company,” “we,” “us” or our”) and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended January 1, 2022, filed with the Securities and Exchange Commission on March 17, 2022 (the “2021 Form 10-K”), for additional information.

 

The accompanying condensed consolidated financial statements are unaudited. However, in the opinion of management, all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of the results of operations for interim periods have been reflected therein. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.  All intercompany accounts and transactions are eliminated.

 

The condensed consolidated balance sheet as of January 1, 2022 has been derived from the audited consolidated balance sheet at that date.

 

The Company’s fiscal year is a 52-53-week fiscal year ending on the Saturday nearest to December 31. References to 2021 or the 2021 fiscal year mean the 52-week period ended on January 1, 2022, and references to 2022 or the 2022 fiscal year mean the 52-week period ending on December 31, 2022. In a 52-week fiscal year, each quarter has 13 weeks.  References to the first quarter of 2021, the first fiscal quarter of 2021 or the three months ended April 3, 2021 mean the period from January 3, 2021 to April 3, 2021. References to the first quarter of 2022, the first fiscal quarter of 2022 or the three months ended April 2, 2022, mean the 13-week period from January 2, 2022 to April 2, 2022.

 

Certain amounts in the 2021 financial statements have been reclassified to conform with the 2022 presentation with no impact or change to previously reported net income or shareholder’s equity.

 

Note B – Discontinued Operations

 

In the second quarter of 2021, the Company determined that the companies included in our former Diversified Products segment no longer fit with our long-term strategy and the Company initiated the process of selling the companies within the Diversified Products segment.  Selling the companies within this segment will allow management to focus on our core capabilities and offerings.

 

The former Diversified Products segment met the criteria to be held for sale and furthermore, we determined that the assets held for sale qualify for discontinued operations.  As such, the financial results of the Diversified Products segment are reflected in our unaudited condensed consolidated statements of operations as discontinued operations for all periods presented.  Additionally, current and non-current assets and liabilities of discontinued operations are reflected in the unaudited condensed consolidated balance sheets for both periods presented.

 

On November 3, 2021, the Company sold its Greenwald Industries, Inc. division (“Greenwald”).  Greenwald, located in Chester, CT, is an OEM manufacturer offering a range of payment solutions from coin-vending products to smart card systems and payment applications.

 

On November 22, 2021, the Company sold its Frazer & Jones Company division (“Frazer & Jones”).  Frazer & Jones is a ductile and malleable iron foundry located in Syracuse, NY.  Eastern has exited the mining business to focus on our three core businesses.

 

 
8

Table of Contents

 

Summarized Financial Information of Discontinued Operations

 

The following table represents income from discontinued operations, net of tax:

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

 

(unaudited)

 

 

(unaudited)

 

Net sales

 

$2,367,226

 

 

$11,324,442

 

Cost of products sold

 

 

(1,603,762)

 

 

(9,904,720)

Gross margin

 

 

763,464

 

 

 

1,419,722

 

 

 

 

 

 

 

 

 

 

Selling and administrative expenses

 

 

(257,060)

 

 

(1,032,827)

Operating income

 

 

506,404

 

 

 

386,895

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(35,217)

 

 

(175,714)

Income from discontinued operations before income taxes

 

 

471,187

 

 

 

211,181

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(126,867)

 

 

(49,712)

Income from discontinued operations, net of tax

 

$344,320

 

 

$161,469

 

 

The following table represents the assets and liabilities from discontinued operations:

 

 

 

April 2, 2022

 

 

January 1, 2022

 

 

 

(unaudited)

 

 

 

 

Cash

 

$128,548

 

 

$434,126

 

Accounts receivable

 

 

1,112,294

 

 

 

1,153,274

 

Inventory

 

 

2,539,551

 

 

 

1,258,032

 

Prepaid expenses

 

 

43,293

 

 

 

59,850

 

Property, plant and equipment, net

 

 

571,260

 

 

 

591,920

 

Right of use assets

 

 

276,969

 

 

 

24,697

 

Total assets of discontinued operations¹

 

$4,671,915

 

 

$3,521,899

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$566,653

 

 

$167,794

 

Accrued compensation and other accrued expenses

 

 

382,795

 

 

 

388,499

 

Current portion of lease liability

 

 

92,323

 

 

 

24,697

 

Other long-term liabilities

 

 

184,646

 

 

 

-

 

Total liabilities of discontinued operations¹

 

$1,226,417

 

 

$580,990

 

 

¹ The total assets and liabilities of discontinued operations are classified as current in the April 2, 2022 and 

   January 1, 2022 balance sheets, as we expect to sell the discontinued operations and collect proceeds within one year. 

 

 
9

Table of Contents

 

Note C – Earnings Per Share

 

The denominators used to calculate earnings per share are as follows:

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Basic:

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,247,649

 

 

 

6,248,339

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,247,649

 

 

 

6,248,339

 

Dilutive stock appreciation rights

 

 

12,055

 

 

 

30,998

 

Denominator for diluted earnings per share

 

 

6,259,704

 

 

 

6,279,337

 

 

Note D – Inventories

 

Inventories from continuing operations consist of the following components:

 

 

 

April 2, 2022

 

 

January 1, 2022

 

 

 

 

 

 

 

 

Raw material and component parts

 

$27,077,178

 

 

$25,113,487

 

Work in process

 

 

10,389,475

 

 

 

9,636,009

 

Finished goods

 

 

30,311,065

 

 

 

28,112,846

 

Total inventories

 

$67,777,718

 

 

$62,862,342

 

 

Note E - Goodwill

 

The aggregate carrying amount of goodwill from continuing operations is approximately $72.2 million as of April 2, 2022. No impairment was recognized in the first quarter of 2022.

 

The Company tests its reporting units for impairment annually in December, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount.  Such events and circumstances could include, among other things, increased competition or unexpected loss of market share, significant adverse changes in the markets in which the Company operates, or unexpected business disruptions.  The Company tests reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount.  If the carrying amount of a reporting unit exceeds its estimated fair value, the Company records an impairment loss based on the difference between fair value and carrying amount not to exceed the associated carrying amount of goodwill.  Determining the fair value of a reporting unit involves the use of significant estimates and assumptions.  The values assigned to the key assumptions represent management’s assessment of future trends in the relevant industry and have been based on historical data from both external and internal sources.

 

Note F – Leases

 

The Company presents right-of-use (ROU) assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases.  The Company accounts for non-lease components as part of the lease component to which they relate.  Lease accounting involves significant judgements, including making estimates related to the lease term, lease payments, and discount rate.

 

The Company has operating leases for buildings, warehouses, and office equipment.  The Company determines whether an arrangement is, or contains, a lease at contract inception. An arrangement contains a lease if the Company has the right to direct the use of and obtain substantially all the economic benefits of an identified asset. ROU assets and lease liabilities are recognized at lease commencement based on the present value of lease payments over the lease term.  Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.  Most leases include one or more options to renew.  The exercise of lease renewal options is at our sole discretion.  All options to extend, when it is reasonably certain the option will be exercised, have been included in the calculation of the ROU asset and lease liability. 

 

 
10

Table of Contents

 

Currently, the Company has 25 operating leases and three finance leases with a lease liability of $11.8 million as of April 2, 2022. The finance lease arrangements are immaterial. The terms and conditions of the leases are determined by the individual agreements. The leases do not contain residual value guarantees, restrictions, or covenants that could cause the Company to incur additional financial obligations. There are no related party lease transactions. There are no leases that have not yet commenced that could create significant rights and obligations for the Company.

 

Total lease expense for each of the next five fiscal years is estimated to be as follows: remainder of 2022 - $2.2 million; 2023 - $2.6 million; 2024 - $2.1 million; 2025 - $1.2 million; 2026 - $0.8 million; and $2.9 million thereafter. The weighted average remaining lease term is 6.0 years. The implicit interest rate used was 5.0%.

 

Note G - Debt

 

On August 30, 2019, the Company entered into a credit agreement with Santander Bank, N.A., for itself, People’s United Bank, National Association and TD Bank, N.A. as lenders (the “Credit Agreement”), that included a $100 million term portion and a $20 million revolving commitment portion. Proceeds of the term loan were used to repay the Company’s remaining outstanding term loan (and to terminate its existing credit facility) with People’s United Bank, N.A. (approximately $19 million) and to acquire certain subsidiaries of Big 3 Holdings, LLC (collectively “Big 3 Precision”). The term portion of the loan required quarterly principal payments of $1,250,000 for an 18-month period beginning December 31, 2019. The repayment amount then increased to $1,875,000 per quarter beginning September 30, 2021 and continuing through June 30, 2023. The repayment amount then increases to $2,500,000 per quarter beginning September 30, 2023 and continuing through June 30, 2024. The term loan is a 5-year loan with the remaining balance due on August 30, 2024. The revolving commitment portion has an annual commitment fee of 0.25% based on the unused portion of the revolver. The revolving commitment portion has a maturity date of August 30, 2024. As of April 2, 2022, the Company has borrowed $5,000,000 on the revolving commitment portion of the facility at an interest rate of 1.71%. The term loan bears interest at a variable rate based on the LIBOR rate plus an applicable margin of 1.25% to 2.25%, depending on the Company’s senior net leverage ratio. Borrowings under the revolving portion bear interest at a variable rate based on, at the Company’s election, a base rate plus an applicable margin of 0.25% to 1.25% or the LIBOR rate plus an applicable margin of 1.25% to 2.25%, with such margins determined based on the Company’s senior net leverage ratio. The Company’s obligations under the Credit Agreement are secured by a lien on certain of the Company’s and its subsidiaries’ assets pursuant to a Pledge and Security Agreement, dated August 30, 2019, with Santander Bank, N.A., as administrative agent.

 

The Company’s loan covenants under the Credit Agreement require the Company to maintain a senior net leverage ratio not to exceed 4.25 to 1. In addition, the Company is required to maintain a fixed charge coverage ratio to be not less than 1.25 to 1. The Company was in compliance with all of its covenants under the Credit Agreement on April 2, 2022, and through the date of filing this Form 10-Q.

 

On August 30, 2019, the Company entered an interest rate swap contract with Santander Bank, N.A., with an original notional amount of $50,000,000, which was equal to 50% of the outstanding balance of the term loan on that date. The Company has a fixed interest rate of 1.44% on the swap contract and will pay the difference between the fixed rate and LIBOR when LIBOR is below 1.44% and will receive interest when the LIBOR rate exceeds 1.44%. On April 2, 2022, the interest rate for approximately half ($26.8 million) of the term portion was 1.71%, using a one-month LIBOR rate, and 2.94% on the remaining balance ($42.8 million) of the term loan based on a one-month LIBOR rate.

 

The interest rates under the Credit Agreement and the interest rate swap contract are susceptible to changes to the method of determining LIBOR rates and to the phasing out of LIBOR. Information regarding the phasing out of LIBOR is provided below.

 

On July 27, 2017, the Financial Conduct Authority (the “FCA”) (the authority that regulates LIBOR) announced that it would phase out LIBOR by the end of 2021. In December 2020, the ICE Benchmark Administration (the “IBA”) announced a market consultation regarding the extension of US dollar LIBOR tenors through June 30, 2023, which the FCA supports. On March 5, 2021, the IBA released its feedback statement reporting the results of the market consultation. Pursuant to its feedback statement, the IBA ceased publication of all settings of non-US dollar LIBOR and only the one-week and two-month U.S. dollar LIBOR settings on December 31, 2021, with the publication of the remaining U.S. dollar LIBOR settings scheduled to be discontinued after June 30, 2023. The Alternative Reference Rates Committee (ARRC), a financial industry group convened by the Federal Reserve Board, has recommended the use of SOFR to replace LIBOR. The difference between LIBOR and SOFR is that LIBOR is a forward-looking rate which means the interest rate is set at the beginning of the period with payment due at the end. SOFR is a backward-looking overnight rate which has implications for how interest and other payments are based. Changes in the method of calculating the replacement of LIBOR with an alternative rate or benchmark are still in flux, and once an alternate rate is adopted, may adversely affect interest rates and result in higher borrowing costs. This could materially and adversely affect the Company’s results of operations, cash flows and liquidity. We cannot predict the effect of the potential changes to LIBOR or the establishment and use of alternative rates or benchmarks at this time. We are working with our senior lender and may need to renegotiate our credit facilities as LIBOR phases out in June 2023.

 

 
11

Table of Contents

 

Note H - Stock Options and Awards

 

The Eastern Company 2010 Executive Stock Incentive Plan (the “2010 Plan”), for officers, other key employees, and non-employee directors expired in February 2020.  On February 19, 2020, the Board of Directors of the Company (the “Board”) adopted the Eastern Company 2020 Stock Incentive Plan (the “2020 Plan”).   On April 29, 2020, at the Company’s 2020 Annual Meeting of Shareholders, the shareholders of the Company approved and adopted the 2020 Plan.  The 2020 Plan replaced the 2010 Plan.  The Company has no other existing plan pursuant to which equity awards may be granted.

 

Incentive stock options granted under the 2020 Plan must have exercise prices that are not less than 100% of the fair market value of the Company’s common stock on the dates the stock options are granted.  Restricted stock awards may also be granted to participants under the 2020 Plan with restrictions determined by the Compensation Committee of the Board.  Under the 2020 Plan, non-qualified stock options granted to participants will have exercise prices determined by the Compensation Committee of the Board. During the first three months of fiscal 2022, the Company granted 36,200 stock awards that were subject to the meeting of performance measurements.  The Company granted 27,300 stock awards in the first three months of fiscal 2021. For the first three months of fiscal 2022, the Company used an assumption which included an expected term of 4.0 years, volatility deviation of 47.15% and a risk-free rate 2.04% for the purposes of measuring compensation under the Black Scholes Method.  For the first three months of fiscal 2021, the Company used several assumptions which included an expected term of 4.0 years, volatility deviation between 47.25% to 47.54% and a risk-free rate between 0.18% to 0.20% for the purposes of measuring compensation under the Black Scholes Method. 

 

The 2020 Plan also permits the issuance of Stock Appreciation Rights (“SARs”).  The SARs are in the form of an option with a cashless exercise price equal to the difference between the fair value of the Company’s common stock at the date of grant and the fair value as of the exercise date resulting in the issuance of the Company’s common stock.  During the first three months of fiscal 2022 and 2021 the Company did not issue any SARs. 

 

Stock-based compensation expense in connection with SARs previously granted to employees was approximately $113,000 and $113,000 in the first quarter of 2022 and the first quarter of 2021.

 

As of April 2, 2022, there were 763,968 shares of Company common stock reserved and available for future grant under the 2020 Plan.

 

The following tables set forth the outstanding SARs for the period specified:

 

 

 

Three Months Ended

 

 

Year Ended

 

 

 

April 2, 2022

 

 

January 1, 2022

 

 

 

Units

 

 

Weighted Average Exercise Price

 

 

Units

 

 

Weighted Average Exercise Price

 

Outstanding at beginning of period

 

 

180,833

 

 

$22.88

 

 

 

244,001

 

 

$21.87

 

Issued

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

(55,668)

 

 

19.31

 

Forfeited

 

 

-

 

 

 

-

 

 

 

(7,500)

 

 

21.20

 

Outstanding at end of period

 

 

180,833

 

 

 

22.88

 

 

 

180,833

 

 

 

22.88

 

 

 
12

Table of Contents

 

SARs Outstanding and Exercisable

 

 

 

 

 

 

 

 

 

 

 

 

 

Range of Exercise Prices

 

Outstanding as of April 2, 2022

 

 

Weighted Average Remaining Contractual Life

 

 

Weighted Average Exercise Price

 

 

Exercisable as of April 2, 2022

 

 

Weighted Average Remaining Contractual Life

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20.20 - $26.30

 

 

180,333

 

 

 

1.9

 

 

$22.88

 

 

 

118,335

 

 

 

1.4

 

 

$23.30

 

 

The following tables set forth the outstanding stock awards for the period specified:

 

 

 

Three Months Ended

 

 

Year Ended

 

 

 

April 2, 2022

 

 

January 1, 2022

 

 

 

Shares

 

 

Shares

 

Outstanding at beginning of period

 

 

27,300

 

 

 

25,000

 

Issued

 

 

36,200

 

 

 

27,300

 

Exercised

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

(25,000)

Outstanding at end of period

 

 

63,500

 

 

 

27,300

 

 

As of April 2, 2022, outstanding SARs and stock awards had an intrinsic value of $1,722,000.

 

Note I – Share Repurchase Program

 

On May 2, 2018, the Company announced that the Board of Directors of the Company had authorized a new program to repurchase up to 200,000 shares of the Company’s common stock. The Company’s share repurchase program does not obligate it to acquire the Company’s common stock at any specific cost per share.  Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Below is a summary of the Company’s share repurchases during the first quarter of 2022. 

 

Period

 

Total Number of Shares Purchased

 

 

Average Price Paid Per Share

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs

 

 

Maximum Number of Shares that may yet be Purchased Under the Plans or Programs

 

Balance as of January 1, 2022

 

 

69,596

 

 

$25.89

 

 

 

69,596

 

 

 

130,404

 

January 2, 2022 - April 2, 2022

 

 

30,238

 

 

 

25.36

 

 

 

30,238

 

 

 

(30,238)

Balance as of April 2, 2022

 

 

99,834

 

 

$25.73

 

 

 

99,834

 

 

 

100,166

 

 

Note J – Revenue Recognition

 

The Company’s revenues result from the sale of goods and services and reflect the consideration to which the Company expects to be entitled.  The Company records revenues in accordance with FASB Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”.  The Company has defined purchase orders as contracts in accordance with ASC Topic 606. For its customer contracts, the Company identifies its performance obligations, which are delivering goods or services, determines the transaction price, allocates the contract transaction price to the performance obligations (when applicable), and recognizes the revenue when (or as) the performance obligation is transferred to the customer.  A good or service is transferred when the customer obtains control of that good or service.  The Company’s revenues are recorded at a point in time from the sale of tangible products.  Revenues are recognized when products are shipped. 

 

 
13

Table of Contents

 

Customer volume rebates, product returns, discount and allowance are variable consideration and are recorded as a reduction of revenue in the same period that the related sales are recorded.  The Company has reviewed the overall sales transactions for variable consideration and has determined that these costs are not material. 

 

The Company has no future performance obligations and does not capitalize costs to obtain or fulfill contracts. 

 

Note K - Income Taxes

 

The Company files income tax returns in the U.S. federal jurisdiction, and in various states and foreign jurisdictions.  With limited exceptions, the Company is no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2017 and is no longer subject to non-U.S. income tax examinations by foreign tax authorities for years prior to 2015. 

 

The total amount of unrecognized tax benefits could increase or decrease within the next 12 months for several reasons, including the closure of federal, state, and foreign tax years by expiration of the statute of limitations and the recognition and measurement considerations under FASB ASC Topic 740, “Income Taxes.”  There have been no significant changes to the value of unrecognized tax benefits during the three months ended April 2, 2022.  The Company believes that it is reasonably possible that the total amount of unrecognized tax benefits will not increase or decrease significantly over the next twelve months.

 

Note L - Retirement Benefit Plans

 

The Company has four non-contributory defined benefit pension plans covering most U.S. employees.  Three of these pension plans are frozen and participants in these three plans have not accrued benefits since the date on which these plans were frozen.  A fourth pension plan does not permit new participants but existing participants in this fourth pension plan continue to accrue benefits.  Plan benefits are generally based upon age at retirement, years of service and, for the plan covering salaried employees, the level of compensation.  The Company also sponsors unfunded non-qualified supplemental retirement plans that provide certain former officers with benefits in excess of limits imposed by federal tax law. 

 

The Company also provides health care and life insurance for retired salaried employees in the United States who meet specific eligibility requirements.

 

Significant disclosures relating to these benefit plans for the first quarter of fiscal years 2022 and 2021 are as follows:

 

 

 

Pension Benefits

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Service cost

 

$269,744

 

 

$271,833

 

Interest cost

 

 

608,189

 

 

 

504,255

 

Expected return on plan assets

 

 

(1,460,661)

 

 

(1,448,674)

Amortization of prior service cost

 

 

16,563

 

 

 

24,845

 

Amortization of the net loss

 

 

390,075

 

 

 

432,539

 

Net periodic benefit

 

$(176,090)

 

$(215,202)

 

 

 

Other Postretirement Benefits

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Service cost

 

 

13,323

 

 

 

13,626

 

Interest cost

 

 

10,988

 

 

 

9,842

 

Expected return on plan assets

 

 

(4,400)

 

 

(6,420)

Gain on significant event

 

 

-

 

 

 

                       -

 

Amortization of prior service cost

 

 

1,060

 

 

 

-

 

Amortization of the net loss

 

 

(2,054)

 

 

(3,094)

Net periodic benefit cost

 

$18,917

 

 

$13,954

 

 

The Company’s funding policy with respect to its qualified plans is to contribute at least the minimum amount required by applicable laws and regulations.  In fiscal year 2022, the Company expects to contribute $300,000 into its pension plans and $50,000 into its postretirement plan. As of April 2, 2022, the Company has not made any contributions into its pension plans, has contributed $3,000 to its postretirement plan, and expects to make the remaining contributions as required during the remainder of the fiscal year. 

 

The Company has a contributory savings plan under Section 401(k) of the Internal Revenue Code (the “401(k) Plan”) covering substantially all U.S. non-union employees.  The 401(k) Plan allows participants to make voluntary contributions from their annual compensation on a pre-tax basis, subject to limitations under the Internal Revenue Code.  The 401(k) Plan provides for contributions by the Company at its discretion.

 

The Company made contributions to the plan as follows:

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Regular matching contribution

 

$210,939

 

 

$191,808

 

Transitional credit contribution

 

 

51,564

 

 

 

66,929

 

Non-discretionary contribution

 

 

343,377

 

 

 

534,675

 

Total contributions for the period

 

$605,880

 

 

$793,412

 

 

The non-discretionary contribution of $323,082 made in the three months ended April 2, 2022, was accrued for and expensed in the prior fiscal year.

 

 
14

Table of Contents

 

Note M - Recent Accounting Pronouncements

 

Adopted

 

In December 2019, FASB issued ASU 2019-12, Simplifying the Accounting for Income Tax.  The changes implemented in ASU 2019-12 include removing exceptions to incremental intraperiod tax allocation of losses and gains from different financial statement components, exceptions to the method of recognizing income taxes on interim period losses and exceptions to deferred tax liability recognition related to foreign subsidiary investments.  In addition, ASU 2019-12 requires that entities recognize franchise tax based on an incremental method, requires an entity to evaluate the accounting for step-ups in the tax basis of goodwill as inside or outside of a business combination, and removes the requirement to allocate the current and deferred tax provision among entities in standalone financial statement reporting. The ASU also now requires that an entity reflect enacted changes in tax laws in the annual effective rate, and other codification adjustments have been made to employee stock ownership plans.  The Company adopted ASU 2019-12 as of January 3, 2021. The adoption of this guidance did not have a material impact on the consolidated financial statements of the Company.

 

The Company has implemented all new accounting pronouncements that are in effect and that could impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued, but are not yet effective, that might have a material impact on the consolidated financial statements of the Company.

 

Note N - Concentration of Risk

 

Credit Risk

 

Credit risk is the potential financial loss resulting from the failure of a customer or counterparty to settle its financial and contractual obligations to the Company, as and when they become due. The primary credit risk for the Company is its accounts receivable due from customers. The Company has established credit limits for customers and monitors their balances to mitigate the risk of loss.  As of April 2, 2022, there was one significant concentration of credit risk with a customer, who has receivables representing 10% of our total accounts receivable.  One single customer represented more than 11% of the Company’s net accounts receivable as of January 1, 2022.  The maximum exposure to credit risk is primarily represented by the carrying amount of the Company’s accounts receivable.

 

The Company has deposits that exceed amounts up to $250,000 that are insured by the Federal Deposit Insurance Corporation (FDIC), but the Company does not consider this a significant concentration of credit risk based on the strength of the financial institution.

 

Interest Rate Risk

 

The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company’s debt, which bears interest at variable rates based on the LIBOR rate plus a margin spread of 1.25% to 2.25%. The Company has an interest rate swap with a notional amount of $42.8 million on April 2, 2022, to convert a portion of the borrowing under the Credit Agreement from variable to fixed rates. The valuation of this swap is determined using the one-month LIBOR rate index and mitigates the Company's exposure to interest rate risk.  Additionally, interest rates on the Company's debt are susceptible to changes to the method that LIBOR rates are determined and to the potential phasing out of LIBOR after 2021.  The potential phasing out of LIBOR is discussed in greater detail in Note G — Debt hereof and under the heading “The phaseout of the London Interbank Offered Rate (LIBOR), or the replacement of LIBOR with a different reference rate, may adversely affect interest rates” in Part II, Item 8 of the 2021 Form 10-K.

 

Currency Exchange Rate Risk

 

The Company’s currency exposure is concentrated in the British pound, Canadian dollar, Mexican peso, New Taiwan dollar, Chinese RMB and the Hong Kong dollar.  Because of the Company’s limited exposure to any single foreign market, any currency gains or losses have not been material and are not expected to be material in the future.  As a result, the Company does not attempt to mitigate its foreign currency exposure through the acquisition of any speculative or leveraged financial instruments.

 

 
15

Table of Contents

 

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion is intended to highlight significant changes in the financial position and results of operations of The Eastern Company (together with its consolidated subsidiaries, the “Company,” “we,” “us” or “our”) for the quarter ended April 2, 2022. This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended January 1, 2022 and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2022, which was filed with the Securities and Exchange Commission (the “SEC”) on March 17, 2022 (the “2021 Form 10-K”).

 

The Company’s fiscal year is a 52-53-week fiscal year ending on the Saturday nearest to December 31. References to 2021 or the 2021 fiscal year mean the 52-week period ended on January 1, 2022, and references to 2022 or the 2022 fiscal year mean the 52-week period ending on December 31, 2022. In a 52-week fiscal year, each quarter has 13 weeks.   References to the first quarter of 2021, the first fiscal quarter of 2021 or the three months ended April 3, 2021, mean the period from January 3, 2021 to April 3, 2021. References to the first quarter of 2022, the first fiscal quarter of 2022 or the three months ended April 2, 2022, mean the 13-week period from January 2, 2022 to April 2, 2022.

 

Safe Harbor for Forward-Looking Statements

 

Statements contained in this Quarterly Report on Form 10-Q of the Company that are not based on historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.   Forward-looking statements may be identified by the use of forward-looking terminology such as “should,” “could,” “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company’s business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include the scope and duration of the COVID-19 pandemic, including timing of the distribution of  COVID-19 vaccines and rates of vaccination, the extent of resurgences,, the emergence of additional virus variants and how quickly and to what extent normal economic activity can resume, and economic effects of the COVID-19 pandemic, including supply chain disruptions, cost inflation, delays in delivery of our products to our customers, impact on demand for our products, reductions in production levels, increased costs, including costs of raw materials, the impact on global economic conditions, the availability, terms and cost of financing, including borrowings under credit arrangements or agreements, and risks associated with employees working remotely or operating with reduced workforce. Other factors include, but are not limited to risks associated with doing business overseas, including fluctuations in exchange rates and the inability to repatriate foreign cash, the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs and the impact of political, economic and social instability; restrictions on operating flexibility imposed by the agreement governing our credit facility; the inability to achieve the savings expected from global sourcing of materials; the impact of higher raw material and component costs, including the impact of supply chain shortages and inflation, particularly steel, plastics, scrap iron, zinc, copper and electronic components; lower-cost competition; our ability to design, introduce and sell new products and related components; market acceptance of our products;  the inability to attain expected benefits from acquisitions or the inability to effectively integrate such acquisitions and achieve expected synergies; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, energy, oil and gas, transportation, electronic, and general industrial markets; costs and liabilities associated with environmental compliance; the impact of climate change or terrorist threats and the possible responses by the U.S. and foreign governments; failure to protect our intellectual property; cyberattacks; materially adverse or unanticipated legal judgments, fines, penalties or settlements; and other risks identified and discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and Item 1A, Risk Factors, and Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of the 2021 Form 10-K and that may be identified from time to time in our quarterly reports on Form 10-Q, current reports on Form 8-K and other filings we make with the SEC.  Although the Company believes it has an appropriate business strategy and the resources necessary for its operations, future revenue and margin trends cannot be reliably predicted and the Company may alter its business strategies to address changing conditions. Also, the Company makes estimates and assumptions that may materially affect reported amounts and disclosures. These relate to valuation allowances for accounts receivable and excess and obsolete inventories, accruals for pensions and other postretirement benefits (including forecasted future cost increases and returns on plan assets), provisions for depreciation (estimating useful lives), uncertain tax positions, and, on occasion, accruals for contingent losses. The Company undertakes no obligation to update, alter, or otherwise revise any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future events, or otherwise, except as required by law.

 

 
16

Table of Contents

 

Overview

 

COVID-19 Update

 

The COVID-19 pandemic has affected our businesses, including our supply chain, our operations, the labor force, and rising costs throughout 2021 and into 2022.  We continue to follow CDC guidelines, including the use of proper personal protection equipment, social distancing, and sanitizing work areas.  As a result of these measures, the COVID pandemic had minimal impact on our capacity utilization at most of our production facilities in the first quarter of 2022. Many of the Company’s employees have received COVID-19 vaccinations, and we will continue to encourage our workforce to get vaccinated.  In the second quarter of 2022, we are experiencing interruptions in China of our operations and supply base as a result of another variant of COVID-19 and the response to minimize its spread. A more significant resurgence of the COVID-19 pandemic or development of additional severe or highly contagious variants could cause further disruptions in our business and could adversely affect our financial condition, results of operations and cash flow.

 

During the past two years and continuing into 2022, the Company implemented a broad range of policies and procedures to ensure that employees at all our locations remain healthy. Steps that we have taken to reduce the risk of COVID-19 to our employees include, among others: protecting employee health by instructing employees to stay home if they exhibit symptoms of COVID-19; providing standard surgical masks and educating employees on hand hygiene to help stop the spread.  We maintain a clean work environment by frequently cleaning all touch points with products that meet EPA criteria for use against COVID-19; educating employees to clean their personal workspace at the beginning and the end of every shift; and providing hand sanitizer and disposable wipes.  We encourage social distancing, limit in-person meetings, eliminated all non-essential workplace travel and continue to seek and implement additional methods to reduce the risk of COVID-19 to our employees.

 

To the extent our operations will be further affected by COVID-19 in 2022 is dependent on future developments including new COVID variants, effectiveness of vaccines, new medication, and government restrictions.  All these factors could result in further supply chain shortages and resulting cost inflation, increased operating cost, difficulty in finding workers, continued port congestion, and higher shipping costs.  With the inherent uncertainty of the COVID-19 pandemic it is difficult to predict with any confidence the likely impact of the COVID-19 pandemic on our future operations and the extent of the effects it could have on our consolidated business, results of operations and financial condition. For a discussion of certain COVID-19-related risks, see Part I, Item 1A, “Risk Factors”, of the 2021 Form 10-K.

 

General Overview

 

The following analysis excludes discontinued operations.

 

Net sales in the first quarter of 2022 increased 12% to $69.0 million from $61.8 million in the corresponding period in 2021. Sales increased in the first quarter due to increased demand for truck accessories and automotive returnable transport packaging products as well as from distributors.  Our returnable transport packaging sales benefit from the increase in new automotive product launches, including several electric vehicle launches. Our backlog as of April 2, 2022 was up 23% to $85.8 million from $69.7 million as of April 3, 2021.

 

Net sales of existing products increased 4% in the first quarter of 2022 compared to the corresponding period in 2021. Price increases and new products increased net sales by 8% in the first quarter of 2022 compared to the corresponding period in 2021. New products included various truck mirror assemblies, rotary latches, D-rings, and mirror cams. Price increases primarily reflect our efforts to recover an increase in raw material and freight costs.

 

Cost of products sold increased $8.2 million, or 18%, in the first quarter of 2022 compared to the corresponding period in 2021. The increase is primarily due to higher sales volume, as well as increases in the cost of materials and freight rates. The cost of several frequently used raw materials have increased significantly, year-over-year. For example, the cost of most common forms of cold-rolled steel increased 21% between the first quarter of 2021 and the first quarter of 2022; nickel increased 41%; and copper and zinc increased 22% and 33% respectively. Additionally, our freight costs increased $0.4 million, or 18%, in the first quarter of 2022 when compared to the corresponding period in 2021. This increase is due to increased sales volume as shipping demand has exceeded available carriers’ capacity. Price increases to our customers recovered a portion of the increase in raw material costs and freight rates. Finally, the Company paid tariff costs on China-sourced products of approximately $0.6 million in the first quarter of 2022, compared to $0.6 million in the first quarter of fiscal 2021. Most tariffs on China-sourced products have been recovered through price increases.

 

 
17

Table of Contents

 

Gross margin as a percent of sales was 21% in the first quarter of fiscal 2022 compared to 25% in the first quarter of fiscal 2021. Our gross margin in the first quarter of fiscal 2022 reflects the rapid increase in raw material prices.

 

Product development expense increased $0.2 million, or 18% in the first quarter of 2022 when compared to the corresponding period in 2021. As a percentage of net sales, product development costs were 1.7% for the first quarter of 2022 and 1.6% for the corresponding period in 2021.

 

Selling and administrative expense increased $0.9 million, or 10%, in the first quarter of 2022 when compared to the corresponding period in 2021 primarily due to increased commissions and other selling costs, payroll-related expenses, and travel costs. This increase in selling expenses reflect both the increase in sales as well as our investments in sales capabilities.

 

Interest expense decreased $0.1 million in the first quarter of 2022 compared to the corresponding period in 2021.

 

Other income was down $1.9 million in the first quarter of 2022 compared to the corresponding period in 2021. The decrease in other income of $1.9 million in the first quarter was primarily driven by a gain on the sale of the Eberhard Hardware Ltd. building of $1.8 million in the first quarter of 2021.

 

Net income from continuing operations for the first quarter of fiscal 2022 was $2.7 million, or $0.43 per diluted share compared to net income of $5.7 million, or $0.90 per diluted share for the comparable period in 2021.

 

A more detailed analysis of the Company’s results of operations and financial condition follows:

 

Results of Operations

 

The following table shows, for the periods indicated, selected line items from the condensed consolidated statements of operations as a percentage of net sales:

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

 

 

 

 

 

 

Net sales

 

 

100.0%

 

 

100.0%

Cost of products sold

 

 

78.9%

 

 

74.9%

Gross margin

 

 

21.1%

 

 

25.1%

Product development expense

 

 

1.7%

 

 

1.6%

Selling and administrative expense

 

 

14.3%

 

 

14.5%

Operating Profit

 

 

5.1%

 

 

9.0%

 

The following table shows the change in sales and operating profit for the first quarter of fiscal 2022 compared to the first quarter of fiscal 2021 (dollars in thousands):

 

Net Sales

 

$7,241

 

 

 

 

 

 

Volume

 

 

3.4%

Price

 

 

2.9%

New products

 

 

5.4%

 

 

 

11.7%

 

 

 

 

 

Operating Profit

 

$(2,034)

 

 
18

Table of Contents

 

Liquidity and Sources of Capital

 

The Company consumed approximately $3.6 million of cash from continuing operations during the first three months of fiscal 2022 compared to generating approximately $1.3 million during the first three months of fiscal 2021. Cash flow from operations in the first three months of 2022 was lower when compared to the corresponding period last year primarily due to an increase in inventory and accounts receivable partially offset by an increase in accounts payable. The effects of the COVID-19 pandemic are continuing to impact the supply chain and as a result inventories and accounts payable have increased due to increased shipping time, port congestion, and selective pre-buying of raw materials to ensure availability and mitigate the impact of likely future inflationary price increases. Cash flow from operations coupled with cash at the beginning of the 2022 fiscal year and the proceeds from the line of credit were sufficient to fund capital expenditures, debt service, and dividend payments for the first three months of  2022.  On April 8, 2022, the Company drew down an additional $5.0 million on its revolving credit facility to support ongoing working capital requirements brought on by current supply chain constraints. The Company has $10.0 million available on its revolving line of credit.  See Note G - Debt for further discussion on the Company’s debt facilities.

 

Additions to property, plant and equipment for continuing operations were approximately $0.6 million for the first three months of 2022 and $0.6 million for the first three months of 2021. Additionally, in the first three months of 2022 the company received proceeds of $1.3 million from the sale of one of its properties compared to $2.0 million from the sale of one of its facilities in Canada during the first three months of 2021. As of April 2, 2022, there were approximately $0.2 million of outstanding commitments for capital expenditures.

 

The following table shows key financial ratios at the end of each specified period:

 

 

 

First

Quarter

2022

 

 

First

Quarter

2021

 

 

Fiscal

Year

2021

 

Current ratio

 

 

2.7

 

 

 

2.6

 

 

 

2.5

 

Average days’ sales in accounts receivable

 

 

63

 

 

 

63

 

 

 

64

 

Inventory turnover

 

 

3.2

 

 

 

4.3

 

 

 

3.0

 

Total debt to shareholders’ equity

 

 

63.2%

 

 

79.0%

 

 

62.2%

 

The following table shows important liquidity measures as of the balance sheet date for each specified period (in millions):

 

 

 

First

 

 

First

 

 

Fiscal

 

 

 

Quarter

 

 

Quarter

 

 

Year

 

 

 

2022

 

 

2021

 

 

2021

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

- Held in the United States

 

$2.3

 

 

$8.0

 

 

$4.3

 

- Held by a foreign subsidiary

 

 

2.9

 

 

 

9.5

 

 

 

2.3

 

 

 

 

5.2

 

 

 

17.5

 

 

 

6.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Working capital

 

 

83.2

 

 

 

61.5

 

 

 

74.1

 

Net cash (used in) provided by operating activities

 

 

(3.6)

 

 

1.3

 

 

 

(7.8)

Change in working capital impact on net cash used in operating activities

 

 

(8.8)

 

 

(4.3)

 

 

(22.9)

Net cash provided by investing activities

 

 

1.0

 

 

 

1.3

 

 

 

13.6

 

Net cash provided by (used in) financing activities

 

 

1.6

 

 

 

(1.9)

 

 

(20.3)

 

 
19

Table of Contents

 

Inventories of $67.8 million as of April 2, 2022, represent an increase of 7.8% as compared to $62.9 million at the end of fiscal year 2021 and an increase of 56.0% as compared to $43.4 million at the end of the first quarter of fiscal 2021. Accounts receivable, less allowances, were $47.0 million as of April 2, 2022, as compared to $43.2 million at 2021 fiscal year end and $42.2 million at the end of the first quarter of fiscal 2021.

 

Cash, cash flow from operating activities and funds available under the revolving credit portion of the Credit Agreement are expected to be sufficient to cover future foreseeable working capital requirements. However, the Company cannot provide any assurances of the availability of future financing or the terms on which it might be available. In addition, the interest rate on borrowings under the Credit Agreement varies based on our senior net leverage ratio, and the Credit Agreement requires us to maintain a senior net leverage ratio not to exceed 4.25 to 1 and a fixed charge coverage ratio to be not less than 1.25 to 1. A decrease in earnings due to the impact of COVID-19 or the resulting harm to the financial condition of our customers or economic conditions generally, or an increase in indebtedness incurred to offset such a decrease in earnings, would have a negative impact on our senior net leverage ratio and our fixed charge coverage ratio, which in turn would increase the cost of borrowing under the Credit Agreement and could cause us to fail to comply with the covenants under our Credit Agreement.

 

As of the end of the fiscal quarter ended April 2, 2022, the Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Critical Accounting Estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make judgments, estimates and assumptions regarding uncertainties that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. For a full description of our critical accounting policies, refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of the 2021 Form 10-K. While there have been no material changes to our critical accounting estimates, we continue to monitor the methodologies and assumptions underlying such critical accounting estimates.

 

Non-GAAP Financial Measures

 

The non-GAAP financial measures we provide in this report should be viewed in addition to, and not as an alternative for, results prepared in accordance with U.S. GAAP.

 

To supplement the consolidated financial statements prepared in accordance with U.S. GAAP, we have presented Adjusted Net Income from Continuing Operations, Adjusted Earnings Per Share from Continuing Operations and Adjusted EBITDA from Continuing Operations, which are considered non-GAAP financial measures.  The non-GAAP financial measures presented may differ from similarly titled non-GAAP financial measures presented by other companies, and other companies may not define these non-GAAP financial measures in the same way.  These measures are not substitutes for their comparable U.S. GAAP financial measures, such as net sales, net income, diluted earnings per common share, or other measures prescribed by U.S. GAAP, and there are limitations to using non-GAAP financial measures. 

 

 
20

Table of Contents

 

Adjusted Net Income from Continuing Operations is defined as net income from continuing operations excluding, when incurred, certain one-time costs arising from the impacts of impairment losses, gains/losses on the sale of subsidiaries and facilities, transaction expenses primarily relating to acquisitions and divestitures, factory start-up costs, factory relocation expenses and restructuring costs.  Adjusted Net Income from Continuing Operations is a tool that can assist management and investors in comparing our performance on a consistent basis by removing the impact of certain items that management believes do not directly reflect our underlying operating performance.

 

Adjusted Earnings Per Share from Continuing Operations is defined as diluted earnings per share from continuing operations excluding, when incurred, certain per share one-time costs arising from, for example, the impacts of impairment losses, gains/losses on the sale of subsidiaries and facilities, transaction expenses primarily relating to acquisitions and divestitures, factory start-up costs, factory relocation expenses and restructuring costs.  We believe that Adjusted Earnings Per Share from Continuing Operations provides important comparability of underlying operational results, allowing investors and management to access operating performance on a consistent basis.

 

Adjusted EBITDA from Continuing Operations is defined as net income from continuing operations before interest expense, provision for income taxes, and depreciation and amortization and excluding, when incurred, the impacts of certain one-time costs arising from impairment losses, gains/losses on sale of subsidiaries and facilities, transaction expenses primarily relating to acquisitions and divestitures, factory start-up costs, factory relocation expenses and restructuring expenses.  Adjusted EBITDA from Continuing Operations is a tool that can assist management and investors in comparing our performance on a consistent basis by removing the impact of certain items that management believes do not directly reflect our underlying operations.

 

Management uses such measures to evaluate performance period-over-period, to analyze the underlying trends in our business, to assess our performance relative to our competitors, and to establish operational goals and forecasts that are used in allocating resources. These financial measures should not be considered in isolation from, or as a replacement for, U.S. GAAP financial measures.

 

We believe that presenting non-GAAP financial measures in addition to U.S. GAAP financial measures provides investors greater transparency to the information used by our management for its financial and operational decision-making. We further believe that providing this information better enables our investors to understand our operating performance and to evaluate the methodology used by management to evaluate and measure such performance.

 

 
21

Table of Contents

 

Reconciliation of Non-GAAP Measures

Adjusted Net Income and EPS from Continuing Operations Calculation

For the Three Months ended April 2, 2022 and April 3, 2021

($000's)

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Net income from continuing operations as reported per generally accepted accounting principles (GAAP)

 

$2,686

 

 

$5,679

 

 

 

 

 

 

 

 

 

 

Earnings per share from continuing operations as reported under generally accepted accounting principles (GAAP):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.43

 

 

$0.91

 

Diluted

 

$0.43

 

 

$0.90

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

Gain on sale of Eberhard Hardware Ltd building, net of tax

 

 

-

 

 

 

(1,353)A

Loss on sale of Wheeling, IL building, net of tax

 

 

202B

 

 

-

 

Total adjustments (non-GAAP)

 

$202

 

 

$(1,353)

 

 

 

 

 

 

 

 

 

Adjusted net income from continuing operations

 

$2,888

 

 

$4,326

 

 

 

 

 

 

 

 

 

 

Adjusted earnings per share from continuing operations (non-GAAP):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.46

 

 

$0.69

 

Diluted

 

$0.46

 

 

$0.69

 

 

A) Gain on sale of Eberhard Hardware Ltd building                 

B) Loss on sale of ILC building in Wheeling, IL  

               

 
22

Table of Contents

 

Reconciliation of Non-GAAP Measures

Adjusted EBITDA from Continuing Operations Calculation

For the Three Months ended April 2, 2022 and April 3, 2021

($000's)

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

 

 

 

 

 

 

Net income from continuing operations as reported per generally accepted accounting principles (GAAP)

 

$2,686

 

 

$5,679

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

434

 

 

 

527

Provision for income taxes

 

 

881

 

 

 

1,768

 

Depreciation and amortization

 

 

1,830

 

 

 

1,810

 

Gain on sale of Eberhard Hardware Ltd Building

 

 

-

 

 

 

(1,841)A

Loss on sale of Wheeling, IL building

 

 

269B

 

 

-

 

Adjusted EBITDA from continuing operations

 

$6,100

 

 

$7,943

 

 

A) Gain on sale of Eberhard Hardware Ltd building                 

B) Loss on sale of ILC building in Wheeling, IL                 

 

 
23

Table of Contents

 

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a result of the Company’s status as a smaller reporting company pursuant to Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company is not required to provide information under this Item 3.

 

ITEM 4 – CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures:

 

As of April 2, 2022, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (the “CEO”) and the Chief Financial Officer (the “CFO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 240.13a-15(e) and 240.15d-15(e)) pursuant to Exchange Act Rule 13a-15.  As defined in Exchange Act Rules 240.13a-15(e) and 240.15d-15(e), “the term disclosure controls and procedures means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure”.

 

The Company believes that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. The Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, and the CEO and CFO have concluded that these controls and procedures are effective at the “reasonable assurance” level as of April 2, 2022.

 

Changes in Internal Control Over Financial Reporting:

 

During the period covered by this Quarterly Report on Form 10-Q, there were no changes in the Company's internal control over financial reporting that have materially affected or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 
24

Table of Contents

 

PART II – OTHER INFORMATION

 

ITEM 1 – LEGAL PROCEEDINGS

 

The Company is a party to various legal proceedings from time to time related to its normal business operations.  As of the end of the quarter ended April 2, 2022, the Company does not have any material pending legal proceedings, other than as set forth in Part I, Item 3 of the 2021 Form 10-K, or any material legal proceedings known to be contemplated by governmental authorities.

 

ITEM 1A – RISK FACTORS

 

The Company’s business is subject to several risks, some of which are beyond its control. In addition to the other information set forth in this Quarterly Report on Form 10-Q, the Company’s shareholders should carefully consider the risk factors discussed in Part I, Item 1A “Risk Factors” of the 2021 Form 10-K.  These risk factors could have a material adverse effect on the Company’s business, results of operations, financial condition and/or liquidity and could cause our operating results to vary significantly from period to period. As of April 2, 2022, there have been no material changes to the risk factors disclosed in the 2021 Form 10-K. The Company may disclose changes to such risk factors or disclose additional risk factors from time to time in its future filings with the SEC.  Additional risks and uncertainties not currently known to the Company or that it currently deems to be immaterial also may materially adversely affect its business, financial condition, or operating results.

 

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On May 2, 2018, the Company announced that the Board had authorized a new program to repurchase up to 200,000 shares of the Company’s common stock. The Company’s share repurchase program does not obligate it to acquire the Company’s common stock at any specific cost per share.  Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.  Below is a summary of the Company’s share repurchases during the first fiscal quarter of 2022.

 

Period

 

Total Number of Shares Purchased

 

 

Average Price Paid Per Share

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs

 

 

Maximum Number of Shares that may yet be Purchased Under the Plans or Programs

 

January 2, 2022 – January 29, 2022

 

 

10,000

 

 

 

26.33

 

 

 

10,000

 

 

 

120,404

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 30, 2022 – February 26, 2022

 

 

10,000

 

 

 

25.13

 

 

 

10,000

 

 

 

110,404

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

February 27, 2022 – April 2, 2022

 

 

10,238

 

 

 

24.64

 

 

 

10,238

 

 

 

100,166

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

30,238

 

 

$25.36

 

 

 

30,238

 

 

 

100,166

 

 

ITEM 3 – DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4 – MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5 – OTHER INFORMATION

 

None

 

 
25

Table of Contents

 

ITEM 6 – EXHIBITS

 

3.1)

Restated Certificate of Incorporation of the Company, as amended (conformed copy) (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed on May 6, 2020).

 

 

3.2)

Amended and Restated By-Laws of the Company, as amended through March 11, 2022 (incorporated by reference to Exhibit 3(ii) to the Company’s Current Report on Form 8-K filed on March 11, 2022).

 

 

10.1)

Termination Agreement, dated as of January 14, 2022, between the Company and James P. Woidke (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 19, 2022.

 

 

10.2)

Termination Agreement, dated as of March 16, 2022, between the Company and Peter O’Hara (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 17, 2022).

 

 

10.3)

Offer Letter, dated as of March 16, 2022, between the Company and Peter O’Hara.*

 

 

31)

Certifications required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 

 

32)

Certifications pursuant to Rule 13a-14(b) and 18 USC 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

 

 

101)

The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended April 2, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations (Unaudited) for the three months ended April 2, 2022 and April 3, 2021; (ii) Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three ended April 2, 2022, and April 3, 2021; (iii) Condensed Consolidated Balance Sheets (Unaudited) as of April 2, 2022 and January 1, 2022; (iv) Condensed Consolidated Statements of Cash Flows (Unaudited) for the three months ended April 2, 2022 and April 3, 2021; and (iv) Notes to the Condensed Consolidated Financial Statements (Unaudited).**

 

 

104)

Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101). **

 

* Filed herewith.

** Furnished herewith

 

 
26

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

THE EASTERN COMPANY

 

 

 

(Registrant)

 

 

 

 

 

DATE:  May 9, 2022

 

/s/August M. Vlak

 

 

 

August M. Vlak

President and Chief Executive Officer

 

 

 

 

 

DATE:  May 9, 2022

 

/s/John L. Sullivan III

 

 

 

John L. Sullivan III

Vice President and Chief Financial Officer

 

 

 
27

 

  EXHIBIT 10.3

 

 

 

CONFIDENTIAL

 

March 16, 2022

 

Peter O’Hara

614 N Eagle Street

Naperville IL 60563

 

Peter,

 

We are pleased to make this conditional offer for employment with The Eastern Company. The terms of which are outlined below.

 

Title:

Chief Financial Officer, effective May 16, 2022

 

Primary responsibilities:

·         Provide executive leadership in all areas of Finance

·         Lead financial reporting and analysis

·         Oversee financial management, accounting, and controlling functions

·         Lead compliance and risk management

·         Participate in all aspects of mergers, acquisition and divestures

·         Support long term planning process and priorities

 

Location:

Naugatuck, CT

 

Base salary:

$425,000 per year ($8,173.08 per week)

 

Annual target incentive compensation:

Your target incentive will be equal to 40 percent of your base salary earned in a fiscal year and will be based on the achievement of certain annual financial goals.

 

Long term incentive

You will receive a long term incentive award equal to 40 percent of your base salary earned in a fiscal year. Long term incentives are subject to vesting and the achievement of long term financial goals.  We will share a copy of the long term incentive award agreement in April.

 

Termination benefits

You will be eligible for termination benefits in the event of termination without cause or constructive termination.

 

 

112 BRIDGE STREET,  P.O. BOX 460,  NAUGATUCK,  CONNECTICUT  06770-0460

PHONE (203) 729-2255  ●  FAX (203) 723-8653  ●  WWW.EASTERNCOMPANY.COM

 

 

 

Benefits:

·         The Eastern Company health and dental plan and flexible spending accounts

·         Participation in our 401(k) plan, including an automatic 3% company contribution and a 50% matching contribution up to 3% or more of your compensation

·         Life insurance; short- and long-term disability and long-term care coverage, subject to applicable waiting periods

·         Four weeks of vacation; paid time off (PTO) earned on an accrual basis, and company-paid holidays

 

Start date:

 

CFO effective date:

April 4, 2022

 

May 16, 2022

 

This offer of employment is conditional upon the completion of a confidentiality agreement. (See exhibit)

 

*    *    *

 

Peter, we are excited to work with you to realize our ambitious goals for Eastern and look forward to having you onboard.

 

Kind regards,

 

/s/ August Vlak

 

AUGUST VLAK

THE EASTERN COMPANY

 

Accepted by:

/s/ Peter O’Hara

 

 

 

 

Name:

Peter O’Hara

 

 

 

 

Date:   

March 16, 2022

 

 

 
2

 

 

EXHIBIT

 

Reference: Confidentiality and Non-Disclosure Agreement

 

Gentlemen:

 

In consideration of my employment by The Eastern Company, its affiliates, divisions, or subsidiaries (hereinafter “Employer”), and the salary or wages to be paid to me from time to time for services rendered, I, Peter O’Hara, hereby agree, covenant and contract with the Employer as follows:

 

1. Disclosure of Inventions. For the purpose of this Agreement, the word “invention” shall include, but not be limited to, the following: any discovery, idea, device, process, design, development, improvement, conception, concept, application, technique, or invention whether patentable or not, and whether reduced to practice or not. During the term of my employment with Employer and during a period of twenty—four months after termination of such employment, I will promptly disclose to Employer, free from any obligation to me, each and every invention that I, individually or jointly with others, may invent, discover, conceive, or originate, which (i) are related, in any way, to Employers business, or (ii) which results from or may be suggested by any work which I may do for Employer or at Employer’s request, or (iii) which results from the use of the Employer’s facilities or materials.

 

2. Assignment of Inventions. During the term of my employment with Employer and during a period of twenty—four months after termination of such employment, I agree to assign and transfer to the Employer, without any separate remuneration or compensation other than the wages or salary received or compensation paid to me from time to time in the course of my employment by the Employer, my entire right, title and interest in and to all inventions conceived or made by me, together with all United States and foreign patent rights and any other legal protection in and with respect to any and all such inventions. Upon request by the Employer, I agree to execute, and deliver all appropriate patent applications for securing all United States and foreign patents on all such inventions, and to do, execute and deliver any and all acts and instruments that may be necessary or proper to vest all such inventions and patents in the Employer or its designee, and to enable the Employer or its designee to obtain all such letters patent or other legal protection. I agree to render to the Employer or its designee all such assistance as may be required in the prosecution of all such patent applications for the reissue of such patents and in the prosecution or defense of all interferences which may be declared involving any of said patent applications or patents. I further agree not to contest the validity of any patent, United States or foreign, which is issued to the Employer or its designee, on which I made any contribution, or in which I participated in any way, and not to assist any other party in any way in contesting the validity of any such patent.

 

3. Prior Inventions. A complete description of all inventions, applications for patent, and patents in which I personally hold an interest prior to the date of this Agreement are attached hereto as Schedule A. Only those inventions so listed shall be deemed to be excluded from the terms and conditions of this Agreement.

 

 
3

 

 

4. Confidentiality. I understand and acknowledges that I have had and may continue to have access to certain information about the Employer that is not generally known to the public, which shall include, but not be limited to, the following: (i) information regarding operations, assets, liabilities or financial condition; (ii) information regarding bidding, quotations, price, sales merchandising, marketing, capital expenditures, costs, joint ventures, business alliances, products, services or purchasing; (iii) information regarding employees, contractors, subcontractors, sales agents or sales representatives; (iv) customer lists or other information related to customers; (v) information regarding vendors, suppliers, distributors or other business partners; (vi) forecasts, projections, budgets and business plans; (vii) information regarding the planned or pending acquisitions, divestitures or other business combinations; and (viii) trade secrets and proprietary information, together “Confidential Information”. Except in connection with regularly assigned duties for the Employer, I agree that I will not, without prior written approval of an authorized representative of the Employer, divulge or disclose to anyone outside of the Employer, whether by private communication or by public address or publication, or otherwise, any Confidential Information, and will not during my employment by the Employer or at any time thereafter disclose or use for my own benefit such information or Confidential Information, whether or not such Confidential Information were acquired while I was engaged in the Employer’s affairs and regardless of by whom such Confidential Information was generated, either by the Employer or by me or others in the employ of the Employer. All copies of any such Confidential Information, however and wherever produced, shall be and remain the sole property of the Employer and shall not be removed from the premises or custody of the Employer without prior written consent or authorization of an authorized representative of the Employer.

 

5. Return of Property. On termination of my employment, I shall deliver all reports, records, drawings, blueprints, notes, data, memorandum, models, tools and equipment of any nature that are in my possession or under my control and that are the property of Employer or relate to my employment or to the business of Employer.

 

6. Breach of Trust and Injunction. I hereby acknowledge that I will learn and come in contact with certain Confidential Information. I understand that if, either during employment or thereafter, I disclose to others, use for my own benefit, copy, or make notes of any of the Confidential, such conduct will constitute a breach of the confidence and trust bestowed on me by Employer. I recognize that any breach of this Agreement by me is likely to result in irreparable injury to the Employer and agree that the Employer shall be entitled to an injunction restraining me from disclosing or using, in whole or in part, such trade secrets or information or from rendering any services to any person, firm, corporation, association, or other entity to whom such trade secrets or information, in whole or in part, has been disclosed or is threatened to be disclosed. Nothing herein shall be construed as prohibiting the Employer from pursuing any other remedies available to the Employer from such breach or threatened breach, including the recovery of damages from me.

 

7. Good Faith Dealing. I further agree that while employed by Employer and thereafter I will not commit any act interfering with the business, goodwill, trade or customers of the Employer or any subsidiary or affiliated corporations. Furthermore, during such employment and for a period of two years after termination of employment with the Employer, I will not influence or attempt to influence any other employee of the Employer to accept employment with a competitor of the Employer or of any subsidiary or affiliated corporation.

 

8. Non-disparagement. At all times while I am an employee of the Employee and thereafter, I shall not, directly or indirectly, make (or cause to be made) to any person (other than private discussions with my family or legal counsel and, while employed by the Company, my internal business discussions with other employees of the Employer in the ordinary course regarding legitimate business activities of the Employer) any disparaging, derogatory or other negative statement about any member of the Employer, their shareholders or their respective affiliates, or any of their respective officers, directors, employees, or any of their products or services.

 

 
4

 

 

9. Governing Law. The validity, interpretation and performance of this Agreement shall be governed and construed by the law of the State of Connecticut.

 

Signed at _Cleveland, OH________________________, this ______16th____________________

 

day of ___March__________________________, 20_22___.

 

/s/ Peter O’Hara

 

 

 

Peter O’Hara

 

 

 

Accepted by:

 

THE EASTERN COMPANY

 

By

/s/ August Vlak

 

 

 

August Vlak, President & CEO

 

 

 

 

Date

March 16, 2022

 

 

 
5

 

 

EXHIBIT 31

 

 

CERTIFICATIONS

 

I, August M. Vlak, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of The Eastern Company.

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

any fraud, whether or not material, which involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Dated: May 9, 2022 By: /s/August M. Vlak

 

 

August M. Vlak  
   

CEO

 
       

 

EXHIBIT 31

 

CERTIFICATIONS

 

I, John L. Sullivan III, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of The Eastern Company.

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

any fraud, whether or not material, which involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

Dated: May 9, 2022 By: /s/John L. Sullivan III

 

 

John L. Sullivan III  
   

CFO

 

 

 

EXHIBIT 32

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

Pursuant to 18 United States Code Section 1350,

as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, August M. Vlak, the Chief Executive Officer of The Eastern Company (the “Company”) and John L. Sullivan III, the Chief Financial Officer of the Company, hereby certify that, to the best of their knowledge:

 

1)

The Company’s Quarterly Report on Form 10-Q for the Period ended April 2, 2022, and to which this certification is attached as Exhibit 32 (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

 

 

2)

The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

In Witness Whereof, the undersigned have set their hands hereto as of the 9th day of May 2022.

 

By:

/s/August M. Vlak

 

 

August M. Vlak

 

 

CEO

 

By:

/s/John L. Sullivan III

 

 

John L. Sullivan III

 

 

 

 

CFO

 

 

A signed original of this written statement required by Section 906 has been provided to The Eastern Company and will be retained by The Eastern Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

This certification “accompanies” the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q, irrespective of any general incorporation language contained in such filing.)